Table 2.

Correlation between miR-27a, miR-181a, miR20b and relative target genes expression with clinicopathologic characteristics in GC patients.

	miR-27a median level		miR-181a median level		miR-20b median level		MDR-1 median level		HIF1A median level		HIPK2 median level
Age
≤63 (n = 11)	1.11	P = 0.13	1.14	P = 0.2	0.33	P = 0.41	3.02	P = 0.91	1.99	P = 0.75	1.25	P = 0.77
>63 (n = 10)	0.13		0.39		0.22		3.6		2.16		1.56
T
II-III (n = 15)	0.62	P = 0.87	0.66	P = 0.53	0.24	P = 0.45	3.94	P = 0.81	2.27	P = 0.61	1.25	P = 0.34
IV (n = 6)	0.69		0.72		0.27		1.83		1.68		1.56
Lymph nodes status
N0-1-2 (n = 8)	1.17	P = 0.36	0.79	P = 0.46	0.38	P = 0.27	0.80	P = 0.05	1.48	P = 0.32	0.71	P = 0.58
N3 (n = 13)	0.18		0.44		0.21		5.22		2.72		1.48
Gender
F (n = 10)	1.3	P = 0.34	1.08	P = 0.5	0.32	P = 0.37	1.83	P = 0.06	1.68	P = 0.54	1.3	P = 0.39
M (n = 11)	0.27		0.63		0.23		5.54		2.72		1.48